GeneDx Holdings Corp
(NAS:WGS)
$
96.57
-0.47 (-0.48%)
Market Cap: 2.65 Bil
Enterprise Value: 2.65 Bil
PE Ratio: 0
PB Ratio: 12.96
GF Score: 43/100 Sema4 Holdings Corp at Goldman Sachs Global Healthcare Conference Transcript
Jun 16, 2022 / 04:20PM GMT
Release Date Price:
$47.52
(-0.69%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
All right. Welcome, everybody. I'm Matt Sykes, the Life Science Tools and Diagnostics analyst at Goldman Sachs, and I'm pleased to be hosting Sema4 today at our conference. We've got Katherine Stueland, the Chief Executive Officer; and Joel Kaufman, Vice President of Finance and Corporate Development. Katherine, Joel, thanks for joining us.
Katherine A. Stueland
Sema4 Holdings Corp. - CEO & Director
Thank you for having us.
Joel Harrison Kaufman
Sema4 Holdings Corp. - VP of Finance & Corporate Development
Thank you for having us.
Questions & Answers
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
Maybe if we could just kind of start out, you can kind of set the stage for us a little bit and talk about some of the recent changes, there's been many, and sort of your expectations for the course of this year and some of the key
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot